Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.
Currently Operating in One Region
July 24, 2023
/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...Read on PRNewswire »
October 25, 2023
Nina Tandon, a biotech entrepreneur, shares her journey from growing up in New York City to founding her own company. She discusses the challenges she faced and the importance of diversity in the...Read on Brown Girl Magazine »
March 9, 2023
EpiBone, emerging biotech company, is relocating to Jersey City — and bringing nearly 100 jobs | ROI-NJ
EpiBone, an emerging biotechnology company co-founded and run by Nina Marie Tandon, is coming to Jersey City after the Board of the New Jersey Economic Development Authority (NJEDA) approved up to...Read on ROI-NJ »
October 17, 2015
EpiBone uses stem cells to regrow damaged bones. After getting a PhD from Columbia, Nina Tandon returned to school for an MBA to form a company at the forefront of 'biology as design.'Read on Inc.com »
More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on EpiBone and over 386 other ventures working to solve the world's toughest problems.